Angiotensin-converting enzyme inhibition and the norepinephrine spillover response to dynamic exercise

Journal of Applied Physiology

Volumn 81, Issue 3, 1996, Pages 1138-1142

  Leuenberger, Urs ^a   Gaul, Lawrence ^a   Noack, Howard ^a   Gubin, Steven ^a   Zelis, Robert ^a,b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

angiotensin converting enzyme inhibitor; prejunctional angiotensin II receptors; renin angiotensin system; sympathetic nervous system

Indexed keywords

ADRENALIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT; NITROPRUSSIDE SODIUM; NORADRENALIN;

ARTERIAL PRESSURE; ARTICLE; BICYCLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; ENZYME INHIBITION; EXERCISE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; INHIBITION KINETICS; MALE; MATHEMATICAL COMPUTING; NORADRENALIN BLOOD LEVEL; NORADRENALIN RELEASE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0029781558     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1996.81.3.1138     Document Type: Article

References (22)

1. Bayliss, J., R. Canepa-Anson, M. S. Norell, P. Poole-Wilson, and G. Sutton. Vasodilatation with captopril and prazosin in chronic heart failure: double blind study at rest and on exercise. Br. Heart J. 55: 265-273, 1986.
2. Cleland, J. G. F., D. Shah, S. Krikler, A. Dritsas, P. Nihoyannopoulos, G. Frost, and C. M. Oakley. Effects of lisinopril on cardiorespiratory, neuroendocrine, and renal function in patients with asymptomatic left ventricular dysfunction. Br. Heart J. 69: 512-515, 1993.
3. Clemson, B., R. G. Baily, D. Davis, and R. Zelis. Effects of desipramine on norepinephrine clearance in congestive heart failure. Am. J. Physiol. 259 (Endocrinol. Metab. 22): E261-E265, 1990.
4. Clemson, B., L. Gaul, S. S. Gubin, D. M. Campsey, J. McConville, J. Nussberger, and R. Zelis. Prejunctional angiotensin II receptors: facilitation of norepinephrine release in the human forearm. J. Clin. Invest. 93: 684-691, 1994.
5. Davis, D., R. Baily, and R. Zelis. Abnormalities in systemic norepinephrine kinetics in human congestive heart failure. Am. J. Physiol. 254 (Endocrinol. Metab. 17): E760-E766, 1988.
6. Gilbert, E. M., A. Sandoval, P. Larrabee, D. G. Renlund, J. B. O'Connell, and M. R. Bristow. Lisinopril lowers cardiac adrenergic drive and increases β-receptor density in the failing human heart. Circulation 88: 472-480, 1993.
7. Girbes, A. R. J., D. J. Van Veldhuisen, R. G. Grevink, A. J. Smit, and W. D. Reitsma. Effects of ibopamine on exercise-induced increase in norepinephrine in normal men. J. Cardiovasc. Pharmacol. 19: 371-374, 1992.
8. Hasking, G. J., M. D. Esler, G. L. Jennings, D. Burton, J. A. Johns, and P. I. Korner. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous system activity. Circulation 73: 615-621, 1986.
9. Kubo, S. H., R. J. Cody, J. H. Laragh, X. E. Prida, S. A. Atlas, Z. Yuan, and J. E. Sealey. Immediate converting-enzyme inhibition with intravenous enalapril in chronic congestive heart failure. Am. J. Cardiol. 55: 122-126, 1985.
10. Kusaka, M., K. Atarashi, K. Matsumoto, Y. Sumida, T. Shingu, T. Ootsuki, H. Matsuura, and G. Kajiyama. Effects of treatment with captopril on exercise tolerance and plasma catecholamines in elderly hypertensives. J. Hypertens. 7, Suppl. 7: S59-S61, 1989.
11. Lang, C. C., A. R. Rahman, D. J. K. Balfour, and A. D. Struthers. Enalapril blunts the antinatriuretic effect of circulating noradrenaline in man. J. Hypertens. 11: 565-571, 1993.
12. Leimbach, W. N., B. G. Wallin, R. G. Victor, P. E. Aylward, G. Sundlöf, and A. L. Mark. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 73: 913-919, 1986.
13. Leuenberger, U., L. Sinoway, S. Gubin, L. Gaul, D. Davis, and R. Zelis. Effects of exercise intensity and duration on norepinephrine spillover and clearance in humans. J. Appl. Physiol. 75: 668-674, 1993.
14. Nussberger, J., T. Fasanella d'Amore, M. Porchet, B. Waeber, D. B. Brunner, H. R. Brunner, L. Kler, A. N. Brown, and R. J. Francis. Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers. J. Cardiovasc. Pharmacol. 9: 39-44, 1987.
15. Poulsen, K., and J. Jørgensen. An easy radioimmunological microassay of renin activity, concentration and substrate in human and animal plasma and tissues based on angiotensin I trapping by antibody. J. Clin. Endocrinol. Metab. 39: 816-825, 1974.
16. Savard, G. K., E. A. Richter, S. Strange, B. Kiens, N. J. Christensen, and B. Saltin. Norepinephrine spillover from skeletal muscle during exercise in humans: role of muscle mass. Am. J. Physiol. 257 (Heart Circ. Physiol. 26): H1812-H1818, 1989.
17. Staessen, J., R. Fagard, P. Hespel, P. Lijnen, L. Vanhees, and A. Amery. Plasma renin system during exercise in normal men. J. Appl. Physiol. 63: 188-194, 1987.
18. Stead, S. W., and B. C. Bloor. The effects of captopril on the renin-angiotensin system and the sympathetic nervous system during sodium nitroprusside-induced hypotension in the halothane-anesthetized rabbit. J. Cardiovasc. Pharmacol. 15: 465-471, 1990.
19. Sterns, D. A., S. M. Ettinger, K. S. Gray, S. K. Whisler, T. J. Mosher, M. B. Smith, and L. I. Sinoway. Skeletal muscle metaboreceptor exercise responses are attenuated in heart failure. Circulation 84: 2034-2039, 1991.
20. Swedberg, K., P. Eneroth, J. Kjekshus, and L. Wilhelmsen. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation 82: 1730-1736, 1990.
21. Zelis, R., and S. F. Flaim. Alterations in vasomotor tone in congestive heart failure. Prog. Cardiovasc. Dis. 24: 437-459, 1982.
22. Zimmerman, B. G., E. J. Sybertz, and P. C. Wong. Interaction between sympathetic and renin-angiotensin system. J. Hypertens. 2: 581-587, 1984.